AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2025
Oct 3, 2025
34301_dirs_2025-10-03_fe6eebd2-a045-4081-b556-4dc845aca7a0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2025-10-01
Reporting Person: HEDRICK MARC H (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-01 | Common Stock | M | 159681 | — | Acquired | 180106 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-01 | Restricted Stock Units | $0 | M | 159681 | Disposed | Common Stock (159681) | Direct |
Footnotes
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock.
F2: Represents the vesting of an RSU grant which occurs in twelve substantially equal quarterly installments beginning on October 1, 2025.
More from PLUS THERAPEUTICS, INC.
Capital/Financing Update
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Board/Management Information
2026
Apr 9
Regulatory Filings
2026
Apr 8
Board/Management Information
2026
Mar 26
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27